Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

India flag India · Delayed Price · Currency is INR
139.58
-4.26 (-2.96%)
Mar 9, 2026, 3:30 PM IST
-10.01%
Market Cap 2.65B
Revenue (ttm) 4.46B
Net Income (ttm) 431.20M
Shares Out 19.00M
EPS (ttm) 22.69
PE Ratio 6.15
Forward PE n/a
Dividend 2.00 (1.39%)
Ex-Dividend Date Aug 14, 2025
Volume 16,947
Average Volume 16,354
Open 143.10
Previous Close 143.84
Day's Range 138.00 - 144.20
52-Week Range 136.00 - 238.69
Beta 0.51
RSI 44.21
Earnings Date Apr 24, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas,... [Read more]

Sector Materials
Founded 1979
Employees 451
Stock Exchange National Stock Exchange of India
Ticker Symbol NATHBIOGEN
Full Company Profile

Financial Performance

In fiscal year 2025, Nath Bio-Genes (India)'s revenue was 3.65 billion, an increase of 9.70% compared to the previous year's 3.33 billion. Earnings were 386.00 million, a decrease of -2.57%.

Financial Statements

News

Nath Bio-Genes (India) Ltd (BOM:537291) Q2 2026 Earnings Call Highlights: Strong Revenue and ...

Nath Bio-Genes (India) Ltd (BOM:537291) Q2 2026 Earnings Call Highlights: Strong Revenue and Profit Growth Amidst Market Challenges

3 months ago - GuruFocus